Patents by Inventor Mark R. McCormick

Mark R. McCormick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7550447
    Abstract: A suitable carrier molecule useful in a nucleic acid precipitation method is modified by coupling a suitable visualizable indicator molecule to the carrier molecule. The conjugated carrier facilitates nucleic acid precipitation because the presence and location of nucleic acid in a sample is readily observed and monitored.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: June 23, 2009
    Assignee: Merck Patent GmbH
    Inventor: Mark R. McCormick
  • Patent number: 7144713
    Abstract: A suitable carrier molecule useful in a nucleic acid precipitation method is modified by coupling a suitable visualizable indicator molecule to the carrier molecule. The conjugated carrier facilitates nucleic acid precipitation because the presence and location of nucleic acid in a sample is readily observed and monitored.
    Type: Grant
    Filed: October 1, 1996
    Date of Patent: December 5, 2006
    Assignee: EMD Biosciences, Inc.
    Inventor: Mark R. McCormick
  • Patent number: 7008651
    Abstract: There is now a market for kits containing the necessary components for performing protein synthesis reactions using template DNA of the experimenter. One category of existing system for performing protein synthesis reactions is based on an S-30 extract from the bacteria E. coli. It is disclosed here that a simple fractionation process can dramatically improve the performance of an S-30 prokaryotic protein synthesis reaction mixture. In one embodiment, the fractionation is a simple freezing and thawing of an S-30 extract combined with a supplemental mix, followed by centrifugation. The resulting fractionated S-30 reaction mixture yields more full-length target protein and less non-full length or non-target protein than possible using prior art S-30 systems.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: March 7, 2006
    Assignee: EMD Biosciences, Inc.
    Inventors: Yuping Ambuel, Thomas R. Van Oosbree, Mark R. McCormick, Robert C. Mierendorf
  • Publication number: 20020034559
    Abstract: There is now a market for kits containing the necessary components for performing protein synthesis reactions using template DNA of the experimenter. One category of existing system for performing protein synthesis reactions is based on an S-30 extract from the bacteria E. coli. It is disclosed here that a simple fractionation process can dramatically improve the performance of an S-30 prokaryotic protein synthesis reaction mixture. In one embodiment, the fractionation is a simple freezing and thawing of an S-30 extract combined with a supplemental mix, followed by centrifugation. The resulting fractionated S-30 reaction mixture yields more full-length target protein and less non-full length or non-target protein than possible using prior art S-30 systems.
    Type: Application
    Filed: May 3, 2001
    Publication date: March 21, 2002
    Inventors: Yuping Ambuel, Thomas R. Van Oosbree, Mark R. McCormick, Robert C. Mierendorf